Gilead Sciences Inc
Change company Symbol lookup
Select an option...
GILD Gilead Sciences Inc
KINS Kingstone Companies Inc
PBI Pitney Bowes Inc
VRRM Verra Mobility Corp
VGI Virtus Global Multi-Sector Income Fund
FATH Fathom Digital Manufacturing Corp
$NQUSL50206015GBPN Nasdaq Large Cap Commercial Vehicles
BTSR Brightstar Information Technology Group Inc
RL Ralph Lauren Corp
FOXA Fox Corp
Go

Health Care : Biotechnology | Large Cap Value
Company profile

Gilead Sciences, Inc. is a biopharmaceutical company. The Company is engaged in advancing medicines to prevent and treat life-threatening diseases, including human immunodeficiency virus (HIV), viral hepatitis and cancer. The Company offers products in HIV, Onocolgy, Liver Disease, Vekulaery, and Other. Under HIV, it offers Biktarvy, Complera/Eviplera, Genvoya, Odefsey, Stribild, and Truvada. Its Veklury (remdesivir) is a nucleotide analog RNA polymerase inhibitor indicated for the treatment of coronavirus disease 2019 (COVID-19). Under oncology it offers cell therapy containing Tecartus and Yescarta. Under this Liver Disease consists of Chronic hepatitis C virus (HCV) (Ledipasvir/Sofosbuvir and Sofosbuvir/Velpatasvir) and Chronic hepatitis B virus (HBV) / hepatitis delta virus (HDV) (Vemlidy and Viread). The Company's other products include AmBisome and Letairis. It also operates a portfolio of small molecule inhibitors targeting PARP1 for oncology and MK2 for inflammatory diseases.

Closing Price
$74.10
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Average)
Volume:
4,578,676

10-day average volume:
4,466,795
4,578,676
  • Prev Close
    74.10
  • Today's Open
    --
  • Day's Range
    --
  • Avg Vol (10-day)
    4.5M
  • Last (time)
    4:00p ET 10/02/23
  • Last (size)
    10
  • 52-Wk Range
    61.45 - 89.74
    LowHigh
  • (10/03/22 - 12/13/22)
    20.60%
  • 23.6%
  • Market Cap
    92.3B
  • Shares Outstanding
    1.2B
  • 4.35
  • 17.35x
  • $3.00/4.00%
  • Ex-dividend Date
    09/14/23
  • Dividend Pay Date
    09/28/23
  • 0.4
  • 85.45
  • (% of float 09/15/23)
    1.47

Latest News

October 02, 2023
5:00 pm ET
Zacks
4:42 pm ET
MarketWatch
9:00 am ET
BusinessWire
September 29, 2023
4:42 pm ET
MarketWatch
5:20 am ET
Zacks
September 28, 2023
4:43 pm ET
MarketWatch
September 27, 2023
4:43 pm ET
MarketWatch
September 26, 2023
5:00 pm ET
Zacks
4:43 pm ET
MarketWatch
September 25, 2023
4:43 pm ET
MarketWatch
10:05 am ET
Zacks
September 22, 2023
4:42 pm ET
MarketWatch
September 21, 2023
4:43 pm ET
MarketWatch
September 20, 2023
4:42 pm ET
MarketWatch
6:51 am ET
Zacks
5:20 am ET
Zacks
September 19, 2023
4:42 pm ET
MarketWatch
8:30 am ET
BusinessWire
September 18, 2023
5:00 pm ET
Zacks
4:43 pm ET
MarketWatch
4:00 am ET
BusinessWire
September 15, 2023
4:43 pm ET
MarketWatch
September 14, 2023
4:43 pm ET
MarketWatch
9:12 am ET
Zacks
September 13, 2023
4:43 pm ET
MarketWatch
9:01 am ET
PR Newswire
September 12, 2023
4:50 pm ET
Zacks
4:44 pm ET
MarketWatch
1:00 pm ET
Zacks
September 11, 2023
4:43 pm ET
MarketWatch
11:10 am ET
Zacks
10:20 am ET
Zacks
September 10, 2023
3:01 am ET
BusinessWire
September 08, 2023
4:43 pm ET
MarketWatch
September 07, 2023
8:55 pm ET
BusinessWire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.